Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
80 participants
INTERVENTIONAL
2010-10-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Different Viscous Foods and Liquids on Swallowing Sounds
NCT03024333
The Function of Cricothyroid Muscle and Its Impaction on Mandarin Lexical Tones in Unilateral Vocal Fold Paralysis
NCT02184377
Correlation Between Voice Pitch Changes and Tension of Suboccipital Muscles In Normal Subjects
NCT07008859
Impact of Hypnosis for Performing Lumbar Infusion Tests
NCT06419842
Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure
NCT06165536
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Caffeine and hydration.
200 mg of caffeine (over the counter caffeine tablet)
1 liter of water
C2 (200mg of caffeine; 1/2 L of water)
200mg of caffeine (tablet); 1/2 of water
C3(200mg of caffeine; 1 L of water)
Ingestion of 200 mg of caffeine and 1 Liter of water after between pretest and posttest.
C1 (200mg of caffeine, no water)
Ingestion of 200mg of caffeine (tablet); no water ingestion.
Placebo (no caffeine, no water).
No ingestion of caffeine; no ingestion of water between pretest and posttest.
No caffeine, no hydration.
C2 (200mg of caffeine; 1/2 L of water)
200mg of caffeine (tablet); 1/2 of water
C3(200mg of caffeine; 1 L of water)
Ingestion of 200 mg of caffeine and 1 Liter of water after between pretest and posttest.
C1 (200mg of caffeine, no water)
Ingestion of 200mg of caffeine (tablet); no water ingestion.
Placebo (no caffeine, no water).
No ingestion of caffeine; no ingestion of water between pretest and posttest.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C2 (200mg of caffeine; 1/2 L of water)
200mg of caffeine (tablet); 1/2 of water
C3(200mg of caffeine; 1 L of water)
Ingestion of 200 mg of caffeine and 1 Liter of water after between pretest and posttest.
C1 (200mg of caffeine, no water)
Ingestion of 200mg of caffeine (tablet); no water ingestion.
Placebo (no caffeine, no water).
No ingestion of caffeine; no ingestion of water between pretest and posttest.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern Illinois University Carbondale
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Claudia Franca, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Southern Illinois University Carbondale
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern Illinois University Carbondale
Carbondale, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09433
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.